Immunoreactivity for TNNT2 protein was positive in 5, squamous cell carcinoma; 16, adenocarcinoma; 1, large cell carcinoma in 27 patients who received immune checkpoint inhibitors. The gene discussed is TNNT2; the disease is squamous cell carcinoma.